NCT06984965 Role of EEG in Differentiation Between Ischemic and Hemorrhagic Stroke
| NCT ID | NCT06984965 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assiut University |
| Condition | Acute Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-06 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-06 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Searching electrical activity registered by EEG in acute ischemic and hemorrhagic stroke and comparing these parameters to the poststroke recovery patterns to investigate the role of EEG as a differentiation tool and as a predictor of post-stroke recovery.
Eligibility Criteria
Inclusion Criteria: * Age above 18 and below 80 years. * Acute Ischemic stroke: ischemic arteria cerebri media infarct confirmed by MRI. * Acute Hemorrhagic stroke: spontaneous intraparenchymal bleeding confirmed by CT. * Stroke onset \<72 hours before expected time of performing EEG. * First-ever ischemic stroke. * Measurable deficit on the National Institute of Health Stroke Scale (NIHSS). * Able to give and sign informed consent. Exclusion Criteria: * Transient Ischemic Attacks (TIAs). * Greater than 72 hours past the initial insult. * Patients with subarachnoid haemorrhage, traumatic haemorrhage (epidural/subdural bleeding), cerebral venous sinus thrombosis, indication for urgent neurosurgical intervention. * History of other central nervous system diseases. * Any signs unfit for MRI/EEG scan. * Injury or active infection of electrode cap placement area. * Claustrophobia; recognition disorder. * Known skull defect or head trauma. * Previous neurological procedure (metallic implant, brain pace, cranial operation history). * Significant physical impairment that would restrict the ability to use the portable EEG devices. * Presence of malignancy or systemic rheumatic disease * Non-stroke disease or lesion affecting the sensorimotor system. * Alcohol or drug addiction. * Presence of pump/shunt. * Presence of Malignancy. * Presence of severe cognitive impairment. * History of epilepsy or taking medication due to epilepsy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06984965 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06984965 currently recruiting?
Yes, NCT06984965 is actively recruiting participants. Contact the research team at genaelassall312@gmail.com for enrollment information.
Where is the NCT06984965 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT06984965 clinical trial?
NCT06984965 is sponsored by Assiut University. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.